Addressing the need for a tool that helps predict the poorly understood and sometimes fatal incidences of drug-induced liver injury, the non-profit Hamner Institutes for Health Sciences is partnering with Entelos to create a computer model of liver function in virtual patients.

The partnership, for which no financial details were made public, is set to run for two years and will combine Entelos' experience developing its PhysioLab biosimulation platform with Hamner’s knowledge of liver injury and systems biology, the partners said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.